Table 1 Demographic characteristics and antibody profile of APS and SNAPS patients
APS | SNAPS | SLE | SS | RA | AS | HC | |
|---|---|---|---|---|---|---|---|
Numbers | 192 | 90 | 103 | 29 | 31 | 30 | 120 |
Age (Q1–Q3) | 35 (30–46) | 39 (32–51) | 34 (29–43) | 42 (35–51) | 47 (40–58) | 34.5 (27–40) | 39 (34–46) |
Sex (F/M) | 162/30 | 77/13 | 92/8 | 27/2 | 28/3 | 15/15 | 108/12 |
Arterial thrombosis | 74 (39%) | 53 (59%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Venous thrombosis | 78 (41%) | 33 (37%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Early fetal loss | 36 (22%) | 12 (16%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Late fetal loss | 81 (50%) | 18 (23%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
aCL IgG/IgM(+) | 115 (60%) | 0 (0%) | 6 (6%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
aB2GPI IgG/IgM(+) | 130 (68%) | 0 (0%) | 13 (13%) | 0 (0%) | 0 (0%) | 1 (3%) | 0 (0%) |
LA(+) | 133 (69%) | 0 (0%) | 6 (6%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
aCL IgA(+) | 80 (42%) | 11 (12%) | 12 (12%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
aB2GPI IgA(+) | 75 (39%) | 9 (10%) | 7 (7%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
aPS/PT IgG(+) | 137 (71%) | 32 (36%) | 15 (15%) | 1 (3%) | 0 (0%) | 0 (0%) | 0 (0%) |
aPS/PT IgM(+) | 141 (73%) | 32 (36%) | 33 (32%) | 7 (24%) | 0 (0%) | 3 (10%) | 5 (4%) |
aB2GPI D1 IgG(+) | 119 (62%) | 14 (16%) | 7 (7%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (2%) |